A study by Lieberman et al., has shown abnormalover-expression of RAD9 in approximately 45% of clinically detectedprostate tumors, and its significant correlation with tumor stage (Lieberman et al., 2018).However, the role of RAD9A in OS is has not been explored. The gene discussed is RAD9A; the disease is neoplasm.